/NMTC
NMTC Stock - NeuroOne Medical Technologies Corporation
Healthcare|Medical - DevicesNASDAQ
$0.73+2.53%
+$0.02 (+2.53%) • Dec 19
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+308.6%upside
Target: $3.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NMTC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.73 – $0.74
TARGET (TP)$3.00
STOP LOSS$0.68
RISK/REWARD1:41.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.69
52W High$1.39
52W Low$0.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $12.10M | $3.45M | $1.95M | $171,169 | $178,146 |
| Gross Profit | $8.14M | $1.08M | $456,517 | $-70,794 | $-97,749 |
| Gross Margin | 67.3% | 31.3% | 23.4% | -41.4% | -54.9% |
| Operating Income | $-4,226,473 | $-11,887,209 | $-11,955,250 | $-10,030,765 | $-10,218,211 |
| Net Income | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 | $-9,948,168 |
| Net Margin | -29.8% | -356.7% | -607.4% | -5842.0% | -5584.3% |
| EPS | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 |
Company Overview
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$1
Average Target
↑ 97.5% Upside
Now
$1
Low
$1
Average
$1
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 5th 2025 | Ladenburg Thalmann | Initiation | Buy | $1.45 |
Earnings History & Surprises
NMTCBeat Rate
44%
Last 16 quarters
Avg Surprise
+14.6%
EPS vs Estimate
Beats / Misses
7/5
4 met exactly
Latest EPS
$-0.04
Q4 2025
EPS Surprise History
Q1 24
0.0%
$-0.14vs$-0.14
Q2 24
-10.0%
$-0.11vs$-0.10
Q3 24
-11.1%
$-0.10vs$-0.09
Q4 24
-22.2%
$-0.11vs$-0.09
Q1 25
+160.0%
$0.06vs$-0.10
Q2 25
+22.2%
$-0.07vs$-0.09
Q3 25
+40.0%
$-0.03vs$-0.05
Q4 25
-10.5%
$-0.04vs$-0.04
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | — | — | — | — |
Q4 2025 | Dec 16, 2025 | $-0.04 | $-0.04 | -10.5% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q2 2025 | May 13, 2025 | $-0.09 | $-0.07 | +22.2% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $-0.10 | $0.06 | +160.0% | ✓ BEAT |
Q4 2024 | Dec 17, 2024 | $-0.09 | $-0.11 | -22.2% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-0.09 | $-0.10 | -11.1% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-0.10 | $-0.11 | -10.0% | ✗ MISS |
Q1 2024 | Feb 13, 2024 | $-0.14 | $-0.14 | 0.0% | = MET |
Q4 2023 | Dec 14, 2023 | $-0.17 | $-0.13 | +23.5% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.20 | $-0.20 | 0.0% | = MET |
Q2 2023 | May 11, 2023 | $-0.20 | $-0.21 | -5.0% | ✗ MISS |
Q1 2023 | Feb 13, 2023 | $-0.11 | $-0.11 | 0.0% | = MET |
Q4 2022 | Dec 22, 2022 | $-0.11 | $-0.09 | +18.2% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-0.22 | $-0.17 | +22.7% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $-0.20 | $-0.19 | +5.0% | ✓ BEAT |
Q1 2022 | Feb 14, 2022 | $-0.18 | $-0.18 | 0.0% | = MET |
Q4 2021 | Dec 15, 2021 | — | $-0.22 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-0.25 | — | — |
Latest News
NeuroOne Medical Tech Q4 EPS $(0.04), Inline, Sales $2.741M Beat $2.470M Estimate
📈 PositiveBenzinga•Dec 17, 2025, 11:40 AM
NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand
➖ NeutralBenzinga•Oct 6, 2025, 08:40 PM
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3
📈 PositiveBenzinga•Sep 9, 2025, 02:23 PM
NeuroOne Announces FDA 510(k) Clearance For Its OneRF Trigeminal Nerve Ablation System In Treatment Of Facial Pain
📈 PositiveBenzinga•Aug 18, 2025, 12:31 PM
NeuroOne Medical Technologies Files Prospectus For $6.75M Share Sale
➖ NeutralBenzinga•Aug 15, 2025, 08:50 PM
NeuroOne Medical Technologies GAAP EPS of -$0.07
📉 NegativeSeeking Alpha•May 13, 2025, 11:58 AM
Frequently Asked Questions about NMTC
What is NMTC's current stock price?
NeuroOne Medical Technologies Corporation (NMTC) is currently trading at $0.73 per share. The stock has moved +2.53% today.
What is the analyst price target for NMTC?
The average analyst price target for NMTC is $3.00, based on 1 analyst.
What sector is NeuroOne Medical Technologies Corporation in?
NeuroOne Medical Technologies Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is NMTC's market cap?
NeuroOne Medical Technologies Corporation has a market capitalization of $0.04 billion, making it a small-cap company.
Does NMTC pay dividends?
No, NeuroOne Medical Technologies Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATHE
Alterity Therapeutics Limited
$3.09
Mkt Cap: $0.1B
BDMD
Baird Medical Investment Holdings Limited
$1.39
Mkt Cap: $0.1B
CTSO
Cytosorbents Corporation
$0.64
Mkt Cap: $0.0B
ECOR
electroCore, Inc.
$4.60
Mkt Cap: $0.0B
HYPD
Hyperion DeFi, Inc.
$3.67
Mkt Cap: $0.0B
MYO
Myomo, Inc.
$0.93
Mkt Cap: $0.0B
RBOT
Vicarious Surgical Inc.
$2.17
Mkt Cap: $0.0B
STRR
Star Equity Holdings, Inc.
$10.95
Mkt Cap: $0.0B
YI
111, Inc.
$3.69
Mkt Cap: $0.0B
ZYXI
Zynex, Inc.
$0.29
Mkt Cap: $0.0B
Explore stocks similar to NMTC for comparison